Beta Blockers May Also Help Lung Cancer Patients Live Longer.
New analysis suggests that beta blockers, medications that are cast-off to control blood compel and heart rhythms, may also help lung cancer patients live longer. The researchers found that patients with non-small-cell lung cancer being treated with shedding lived 22 percent longer if they were also taking these drugs extramale.men. "These findings were the first, to our knowledge, demonstrating a survival forward associated with the use of beta blockers and emission therapy for lung cancer," said lead researcher Dr Daniel Gomez, an helper professor in the department of radiation oncology at the University of Texas MD Anderson Cancer Center in Houston.
So "The results presume that there may be another mechanism, largely unexplored, that could potentially mitigate the rates of tumor spread in patients with this very aggressive disease". The set forth was published Jan 9, 2013 in the Annals of Oncology this site. For the study, Gomez's tandem compared the outcomes of more than 700 patients undergoing radiation therapy for lung cancer.
The investigators found that the 155 patients taking beta blockers for core problems lived an average of almost two years, compared with an typical of 18,6 months for patients not taking these drugs. The findings held even after adjusting for other factors such as age, division of the disease, whether or not chemotherapy was given at the same time, presence of chronic obstructive pulmonary c murrain and aspirin use, the researchers noted. Beta blockers also improved survival without the disease spreading to other parts of the body and survival without the disability recurring.
Sunday, 17 February 2019
New Features Of The Immune System
New Features Of The Immune System.
A unripe enquiry has uncovered evidence that most cases of narcolepsy are caused by a misguided immune system attack - something that has been hunger suspected but unproven. Experts said the finding, reported Dec 18, 2013 in Science Translational Medicine, could outrun to a blood test for the sleep disorder, which can be abstruse to diagnose. It also lays out the possibility that treatments that focus on the immune system could be used against the disease proextender como usarlo yulin. "That would be a desire way out," said Thomas Roth, director of the Sleep Disorders and Research Center at Henry Ford Hospital, in Detroit.
So "If you're a narcolepsy case now, this isn't universal to change your clinical care tomorrow," added Roth, who was not active in the study. Still the findings are "exciting," and advance the understanding of narcolepsy. Narcolepsy causes a fluctuate of symptoms, the most common being excessive sleepiness during the day pennis size increase medicine in churchill. But it may be best known for triggering potentially treacherous "sleep attacks".
In these, people fall asleep without warning, for anywhere from a few seconds to a few minutes. About 70 percent of hoi polloi with narcolepsy have a symptom called cataplexy - unwonted bouts of muscle weakness. That's known as type 1 narcolepsy, and it affects unmercifully one in 3000 people, according to the US National Institute of Neurological Disorders and Stroke. Research shows that those kin have low levels of a brain chemical called hypocretin, which helps you stay awake.
And experts have believed the deficiency is to all intents and purposes caused by an abnormal immune system attack on the knowledge cells that produce hypocretin. "Narcolepsy has been suspected of being an autoimmune disease," said Dr Elizabeth Mellins, a ranking author of the study and an immunology researcher at Stanford University School of Medicine, in California. "But there's never fact been proof of immune system activity that's any sundry from normal activity". Mellins thinks her team has uncovered "very strong evidence" of just such an underlying problem. The researchers found that race with narcolepsy have a subgroup of T cells in their blood that respond to particular portions of the hypocretin protein - but narcolepsy-free people do not.
T cells are a humour part of immune system defenses against infection. That finding was based on 39 plebeians with type 1 narcolepsy, and 35 people without the disorder - including four sets of twins in which one look-alike was affected and the other was not. It's known that genetic susceptibility plays a function in narcolepsy. And the theory is that in people with that inherent risk, certain environmental triggers may cause an autoimmune feedback against the body's own hypocretin.
A unripe enquiry has uncovered evidence that most cases of narcolepsy are caused by a misguided immune system attack - something that has been hunger suspected but unproven. Experts said the finding, reported Dec 18, 2013 in Science Translational Medicine, could outrun to a blood test for the sleep disorder, which can be abstruse to diagnose. It also lays out the possibility that treatments that focus on the immune system could be used against the disease proextender como usarlo yulin. "That would be a desire way out," said Thomas Roth, director of the Sleep Disorders and Research Center at Henry Ford Hospital, in Detroit.
So "If you're a narcolepsy case now, this isn't universal to change your clinical care tomorrow," added Roth, who was not active in the study. Still the findings are "exciting," and advance the understanding of narcolepsy. Narcolepsy causes a fluctuate of symptoms, the most common being excessive sleepiness during the day pennis size increase medicine in churchill. But it may be best known for triggering potentially treacherous "sleep attacks".
In these, people fall asleep without warning, for anywhere from a few seconds to a few minutes. About 70 percent of hoi polloi with narcolepsy have a symptom called cataplexy - unwonted bouts of muscle weakness. That's known as type 1 narcolepsy, and it affects unmercifully one in 3000 people, according to the US National Institute of Neurological Disorders and Stroke. Research shows that those kin have low levels of a brain chemical called hypocretin, which helps you stay awake.
And experts have believed the deficiency is to all intents and purposes caused by an abnormal immune system attack on the knowledge cells that produce hypocretin. "Narcolepsy has been suspected of being an autoimmune disease," said Dr Elizabeth Mellins, a ranking author of the study and an immunology researcher at Stanford University School of Medicine, in California. "But there's never fact been proof of immune system activity that's any sundry from normal activity". Mellins thinks her team has uncovered "very strong evidence" of just such an underlying problem. The researchers found that race with narcolepsy have a subgroup of T cells in their blood that respond to particular portions of the hypocretin protein - but narcolepsy-free people do not.
T cells are a humour part of immune system defenses against infection. That finding was based on 39 plebeians with type 1 narcolepsy, and 35 people without the disorder - including four sets of twins in which one look-alike was affected and the other was not. It's known that genetic susceptibility plays a function in narcolepsy. And the theory is that in people with that inherent risk, certain environmental triggers may cause an autoimmune feedback against the body's own hypocretin.
The USA Is Expected Outbreak Of The Virus Chikungunya (CHIKV)
The USA Is Expected Outbreak Of The Virus Chikungunya (CHIKV).
It's reachable that a life-or-death mosquito-borne virus - with no known vaccine or healing - could migrate from Central Africa and Southeast Asia to the United States within a year, unique research suggests. The chances of a US outbreak of the Chikungunya virus (CHIKV) varies by occasion and geography, with those regions typified by longer stretches of warm weather facing longer periods of on a trip risk, according to the researchers' new computer model get more info. "The only way for this ailment to be transmitted is if a mosquito bites an infected human and a few days after that it bites a healthy individual, transmitting the virus," said chew over lead author Diego Ruiz-Moreno, a postdoctoral associate in the concern of ecology and evolutionary biology at Cornell University in Ithaca, NY "The repetition of this arrangement of events can lead to a disease outbreak".
And that, Ruiz-Moreno said, is where weather comes into the picture, with computer simulations revealing that the chance of an outbreak rises when temperatures, and therefore mosquito populations, rise. The investigate analyzed possible outbreak scenarios in three US locales effects. In 2013, the New York ambit is set to face its highest risk for a CHIKV outbreak during the furious months of August and September, the analysis suggests.
By contrast, Atlanta's highest-risk period was identified as longer, beginning in June and tournament through September. Miami's consistent warm weather means the region faces a higher peril all year. "Warmer weather increases the length of the period of high risk," Ruiz-Moreno said. "This is notably worrisome if we think of the effects of climate change over common temperatures in the near future".
Ruiz-Moreno discussed his team's research - funded in part by the US National Institute for Food and Agriculture - in a brand-new issue of the journal PLoS Neglected Tropical Diseases. CHIKV was prime identified in Tanzania in 1953, the authors noted, and the severe communal and muscle pain, fever, fatigue, headaches, rashes and nausea that can result are sometimes topsy-turvy with symptoms of dengue fever.
It's reachable that a life-or-death mosquito-borne virus - with no known vaccine or healing - could migrate from Central Africa and Southeast Asia to the United States within a year, unique research suggests. The chances of a US outbreak of the Chikungunya virus (CHIKV) varies by occasion and geography, with those regions typified by longer stretches of warm weather facing longer periods of on a trip risk, according to the researchers' new computer model get more info. "The only way for this ailment to be transmitted is if a mosquito bites an infected human and a few days after that it bites a healthy individual, transmitting the virus," said chew over lead author Diego Ruiz-Moreno, a postdoctoral associate in the concern of ecology and evolutionary biology at Cornell University in Ithaca, NY "The repetition of this arrangement of events can lead to a disease outbreak".
And that, Ruiz-Moreno said, is where weather comes into the picture, with computer simulations revealing that the chance of an outbreak rises when temperatures, and therefore mosquito populations, rise. The investigate analyzed possible outbreak scenarios in three US locales effects. In 2013, the New York ambit is set to face its highest risk for a CHIKV outbreak during the furious months of August and September, the analysis suggests.
By contrast, Atlanta's highest-risk period was identified as longer, beginning in June and tournament through September. Miami's consistent warm weather means the region faces a higher peril all year. "Warmer weather increases the length of the period of high risk," Ruiz-Moreno said. "This is notably worrisome if we think of the effects of climate change over common temperatures in the near future".
Ruiz-Moreno discussed his team's research - funded in part by the US National Institute for Food and Agriculture - in a brand-new issue of the journal PLoS Neglected Tropical Diseases. CHIKV was prime identified in Tanzania in 1953, the authors noted, and the severe communal and muscle pain, fever, fatigue, headaches, rashes and nausea that can result are sometimes topsy-turvy with symptoms of dengue fever.
Subscribe to:
Posts (Atom)